The diagnostic accuracy (sensitivity and specificity) of KRAS mutation testing was assessed across all included studies in an analysis that compared patients with pancreatic cancer with all other test subjects (pancreatitis, benign tumours and healthy patients). The gene discussed is KRAS; the disease is pancreatic neoplasm.